Background Recently factors in the relationship between gut microbiota, obesity, diabetes
and the metabolic syndrome have been suggested in the development and progression of …

Introduction Nonalcoholic steatohepatitis (NASH) is characterized by the presence of
steatosis, inflammation, and ballooning degeneration of hepatocytes, with or without fibrosis …

Background and aim Considering the increasing prevalence of non-alcoholic steatohepatitis
(NASH) and treatment gaps, this study aimed to evaluate the effect of probiotic …

Background Promising results in improvement of nonalcoholic fatty liver disease and
nonalcoholic steatohepatitis (NASH) have been identified following probiotic (PRO) …

Purpose In obesity and diabetes the liver is highly susceptible to abnormal uptake and
storage of fat. In certain individuals hepatic steatosis predisposes to the development of non …

Nonalcoholic fatty liver disease is the most prevalent chronic liver disease in Western
countries; it can progress to nonalcoholic steatohepatitis (NASH), cirrhosis and …

ABSTRACT Background & Aims: Non-alcoholic steatohepatitis (NASH) has multifactorial
etiopathogenesis, and intestinal microbiota is co-responsible in this process. The aim of this …

OBJECTIVE To evaluate the therapeutic effect of a probiotic cocktail containing Lactobacilli,
Bifidobacteria and Streptococcus thermophilus on non‐alcoholic steatohepatitis (NASH) …

Background The human gut microbiota has profound influence on host metabolism and
immunity. This study characterized the fecal microbiota in patients with nonalcoholic …

ABSTRACT Background & Aims: Modulation of the gut microbiota emerges as a therapeutic
possibility to improve health. Our objective was to compare the impact of three months of …